1. Home
  2. INTS vs TRUG Comparison

INTS vs TRUG Comparison

Compare INTS & TRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTS
  • TRUG
  • Stock Information
  • Founded
  • INTS 2012
  • TRUG 1983
  • Country
  • INTS United States
  • TRUG United States
  • Employees
  • INTS N/A
  • TRUG N/A
  • Industry
  • INTS Biotechnology: Pharmaceutical Preparations
  • TRUG
  • Sector
  • INTS Health Care
  • TRUG
  • Exchange
  • INTS Nasdaq
  • TRUG NYSE
  • Market Cap
  • INTS 8.4M
  • TRUG 7.0M
  • IPO Year
  • INTS 2023
  • TRUG N/A
  • Fundamental
  • Price
  • INTS $0.28
  • TRUG $5.46
  • Analyst Decision
  • INTS Strong Buy
  • TRUG Strong Buy
  • Analyst Count
  • INTS 2
  • TRUG 1
  • Target Price
  • INTS $6.75
  • TRUG $100.00
  • AVG Volume (30 Days)
  • INTS 5.7M
  • TRUG 457.4K
  • Earning Date
  • INTS 08-11-2025
  • TRUG 08-13-2025
  • Dividend Yield
  • INTS N/A
  • TRUG N/A
  • EPS Growth
  • INTS N/A
  • TRUG N/A
  • EPS
  • INTS N/A
  • TRUG N/A
  • Revenue
  • INTS N/A
  • TRUG $22,236,072.00
  • Revenue This Year
  • INTS N/A
  • TRUG $9.66
  • Revenue Next Year
  • INTS N/A
  • TRUG $48.94
  • P/E Ratio
  • INTS N/A
  • TRUG N/A
  • Revenue Growth
  • INTS N/A
  • TRUG 8.40
  • 52 Week Low
  • INTS $0.26
  • TRUG $4.81
  • 52 Week High
  • INTS $4.94
  • TRUG $73.50
  • Technical
  • Relative Strength Index (RSI)
  • INTS 35.87
  • TRUG 41.94
  • Support Level
  • INTS $0.32
  • TRUG $4.81
  • Resistance Level
  • INTS $0.36
  • TRUG $7.20
  • Average True Range (ATR)
  • INTS 0.03
  • TRUG 0.84
  • MACD
  • INTS 0.00
  • TRUG 0.12
  • Stochastic Oscillator
  • INTS 1.88
  • TRUG 17.62

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

About TRUG TRUGOLF HOLDINGS INC

TruGolf Holdings Inc is a indoor golf gaming solutions company. It has built video games (including Links, a sports game for PC), hardware solutions, and an all-new e-sports platform to connect golfers around the world with E6 CONNECT.

Share on Social Networks: